Summary
PHOREVER will develop a cutting-edge multi-sensing platform capable of detecting extracellular vesicles (EVs) as small as 140 nm, identifying disease-specific proteins (biomarkers) on their membrane surfaces, and determining EV concentrations in human blood samples. This...